| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017526 Generation of protein hydrolysate for use as flavoring agent in foods and medicines; obtain protein, incubate with protease, recover cleavage product |
| 01/23/2003 | US20030017498 Nucleotide sequences coding polypeptides for use as tools in pharmacology, diagnostics, biosensors and bioreactors |
| 01/23/2003 | US20030017495 Enterococcus faecalis polynucleotides and polypeptides |
| 01/23/2003 | US20030017494 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017463 Nucleotide sequence coding polypeptide for use in the treatment of heart, cancer and skin disorders |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017156 Immunogenic polypeptide |
| 01/23/2003 | US20030017150 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017141 Treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 01/23/2003 | CA2453557A1 Keratin-based products and methods for their productions |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453388A1 Factor viii separation |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/23/2003 | CA2449243A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277764A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1276907A2 Viral vectors for use in monitoring hiv drug resistance |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276877A2 Agent for postoperative use after the removal of bone tumours |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276866A2 Novel compounds |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP1276496A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 01/22/2003 | EP0832199A4 Fucosyltransferase genes and uses thereof |
| 01/22/2003 | EP0653067B1 Method and kit for pyridinium crosslink assay |
| 01/22/2003 | EP0627004B1 Improvements in or relating to malaria vaccine |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/22/2003 | CN1392798A Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising same |
| 01/22/2003 | CN1392797A High mannose proteins and method of making mannose proteins |
| 01/22/2003 | CN1392265A Process for preparing bioactive peptide-silk fibroin peptide |
| 01/22/2003 | CN1392264A Process for preparing easy body absorption protein ion and health food produced therefrom |
| 01/22/2003 | CN1392263A Method for preparing easy body absorption protein-calcium by enzyme and health food produced by said protein-calcium |
| 01/22/2003 | CN1392259A CR1 gene ralative to cell reconstitution, conduction and death |
| 01/22/2003 | CN1099462C Medical composition |
| 01/21/2003 | US6509452 Solubilizing the recombinant bacteria with a surfactant or permeabilizing agent which separates native cell proteins from cell membrane without separating the recombinant protein from the cell, wherein the inclusion bodies remain intact |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509447 G protein chimeras and methods of screening compounds |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509177 Cultivating on a medium comprising at least one organic nitrogen or carbon source, in submerged aerated conditions, a Pseudomonas bacterium strain capable of the biosynthesis of pseudomonic acid A |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | US6509017 Vaccines containing nucleic acid fragments encoding antigenic proteins that increase resistance to infection; isolated, purified polypeptide having amino acid sequence 1-598 of seq id no: 6 or 1-600 of seq id no: 8 |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | US6508714 Split spool type flexible coupling |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2063592C Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 01/21/2003 | CA1341417C Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
| 01/21/2003 | CA1341416C Hirudine variants, their use and preparation process |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/16/2003 | WO2003004703A1 Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same |
| 01/16/2003 | WO2003004698A2 Method for monitoring and modulating protein folding |
| 01/16/2003 | WO2003004694A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 01/16/2003 | WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004648A1 Anti_human ovarian cancer -anti_cd3 bispecific antibody |
| 01/16/2003 | WO2003004636A2 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004599A2 Methods of making and using expression constructs for the expression of recombinant proteins |
| 01/16/2003 | WO2003004066A1 Gene therapeutics |
| 01/16/2003 | WO2003003986A2 Parathyroid hormone antibodies and related methods |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002059148A8 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/16/2003 | WO2002043661A3 Recombinant anti-cd30 antibodies and uses thereof |
| 01/16/2003 | WO2002020813A3 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 01/16/2003 | WO2002018644A3 Mass spectrometric analysis of biopolymers |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002002783A3 Expression vectors |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001090192A3 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |